Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis

Cell-penetrating peptide (CPP) based delivery have provided immense potential for the therapeutic applications, however, most of nonhuman originated CPPs carry the risk of possible cytotoxicity and immunogenicity, thus may restricting to be used. Here, we describe a novel human-derived CPP, denoted...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hu, Ma, Jie-Lan, Yang, Ying-Gui, Song, Yang, Wu, Jiao, Qin, Yan-Yan, Zhao, Xue-Li, Wang, Jun, Zou, Li-Li, Wu, Jiang-Feng, Li, Jun-Ming, Liu, Chang-Bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226491/
https://www.ncbi.nlm.nih.gov/pubmed/27081693
http://dx.doi.org/10.18632/oncotarget.8682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226491/
https://www.ncbi.nlm.nih.gov/pubmed/27081693
http://dx.doi.org/10.18632/oncotarget.8682

Ejemplares similares